You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 17, 2025

Drug Price Trends for SM LORATA-DINE D


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SM LORATA-DINE D

Average Pharmacy Cost for SM LORATA-DINE D

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SM LORATA-DINE D 24HR TABLET 49348-0543-57 0.53962 EACH 2025-01-22
SM LORATA-DINE D 24HR TABLET 49348-0543-01 0.53962 EACH 2025-01-22
SM LORATA-DINE D 24HR TABLET 49348-0543-57 0.55364 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Loratadine Market Analysis and Price Projections

Introduction to Loratadine

Loratadine, a non-drowsy antihistamine, is widely used to treat allergic rhinitis and other allergic conditions. Its effectiveness in relieving symptoms such as sneezing, itching, and runny nose has made it a staple in the pharmaceutical industry.

Market Size and Growth

The global loratadine market is experiencing significant growth driven by several key factors. As of 2023, the market size was valued at approximately USD 140.1 million to USD 153.4 million, depending on the source[1][4].

  • Growth Rate: The market is anticipated to grow at a Compound Annual Growth Rate (CAGR) of 2.8% to 3.3% between 2024 and 2032[1][5].
  • Projected Market Size: By 2032, the market is expected to reach USD 0.19 billion to USD 221.4 billion, with varying estimates based on different market segments and regions[2][5].

Key Drivers of Market Growth

Increasing Prevalence of Allergies

The global incidence of allergic rhinitis and other allergic disorders is a major driver. Allergic rhinitis affects approximately 400 million people worldwide, and this number is expected to rise due to changing lifestyles and environmental factors[1][2].

Patient Awareness and OTC Availability

Growing awareness among patients about the over-the-counter (OTC) availability and benefits of loratadine is contributing to market expansion. The convenience of OTC access makes loratadine more accessible and preferred by patients[1].

Diverse Dosage Forms

Loratadine is available in various forms such as tablets, syrups, and dissolvable tablets, catering to different age groups and patient preferences. This diversity in dosage forms further propels market growth[1][4].

Market Segmentation

Dosage Form

  • The tablets segment dominates the market, accounting for a significant share due to patient convenience, ease of administration, and high availability[1][4].

Route of Administration

  • The oral segment holds the largest market share, with approximately 87% of the market in 2023[1].

Type

  • The branded segment dominates the market and is expected to grow at a CAGR of 2.6% over the forecast period[1].

Distribution Channel

  • The hospital pharmacy segment holds the highest market share, but the online pharmacy segment is expected to grow at the fastest CAGR due to increased online platform usage and telemedicine integration[1][4].

Regional Analysis

North America

  • North America is the largest market for loratadine, driven by a high disease burden and the strong presence of several manufacturers. The region is expected to continue its dominance due to increasing prevalence of seasonal and perennial allergies[1][4].

Asia Pacific

  • The Asia Pacific region is predicted to witness the fastest CAGR over the forecast period. Factors such as growing awareness of allergic ailments, a rising geriatric population, and increasing prevalence of lifestyle diseases are driving this growth[4].

Europe and Other Regions

  • Europe, particularly the UK, is also a key player in the global loratadine market, showcasing high growth potential. India and other regions are anticipated to witness lucrative growth during the forecast period[1].

Competitive Landscape

The loratadine market is fragmented, with several pharmaceutical companies competing for market share. Key players include Morepen, Merck Group, Ultratech India Limited, and Vasudha Pharma Chem. These companies are focused on developing improved treatments, such as longer-acting formulations and combination therapies, and engage in growth strategies like partnerships, collaborations, and new product launches[1][5].

Price Projections and Market Dynamics

Competition from Other Antihistamines

Loratadine faces competition from other antihistamines like cetirizine, fexofenadine, and diphenhydramine, which can affect its market share and pricing. The presence of several antihistamine products results in price pressure as companies try to attract price-sensitive customers[3].

Regulatory Compliance

The USP standard grade segment, which emphasizes regulatory compliance with established quality and safety regulations, holds a significant market share. This focus on quality and safety increases customer preference and adoption rates[2][4].

Impact of COVID-19

The COVID-19 pandemic had a moderate impact on the loratadine market. The increased focus on respiratory health and heightened awareness regarding respiratory disease management contributed to market revenue growth. However, the pandemic also highlighted the importance of antihistamines like loratadine in managing allergic conditions[4].

Key Takeaways

  • Growing Demand: The increasing prevalence of allergic disorders globally is driving the demand for loratadine.
  • Diverse Dosage Forms: The availability of loratadine in various forms enhances patient convenience and preference.
  • Regional Growth: North America and the Asia Pacific are key regions driving market growth.
  • Competitive Landscape: The market is fragmented with several players focusing on innovative treatments and strategic partnerships.
  • Price Dynamics: Competition from other antihistamines and regulatory compliance are crucial factors influencing market pricing.

FAQs

1. What is the projected market size of the loratadine market by 2032? The global loratadine market is expected to reach USD 0.19 billion to USD 221.4 billion by 2032, depending on the source[2][5].

2. What is the CAGR of the loratadine market from 2024 to 2032? The market is anticipated to grow at a CAGR of 2.8% to 3.3% between 2024 and 2032[1][5].

3. Which region dominates the loratadine market? North America is the largest market for loratadine, driven by a high disease burden and the strong presence of several manufacturers[1][4].

4. What are the major driving factors of the loratadine market? The increasing prevalence of allergic disorders, patient awareness of OTC availability, and diverse dosage forms are major drivers of the market[1][2].

5. Who are the top companies in the loratadine market? Key players include Morepen, Merck Group, Ultratech India Limited, and Vasudha Pharma Chem[1][5].

Sources

  1. GMI Insights: Loratadine Market Size, Share & Growth Report, 2024 – 2032
  2. The Brainy Insights: Loratadine Market Size, Share, Growth & Trends Report, 2033
  3. Cognitive Market Research: Loratadine API Market Report 2024 (Global Edition)
  4. Grand View Research: Loratadine Market Size, Share, Growth, Trends Report, 2030
  5. Business Research Insights: Loratadine Market Size, Share, Trends Report 2024 To 2032

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.